Ben Franklin Technology Partners of Southeastern Pennsylvania

Astarte Medical Partners, Inc. is a clinical intelligence company focused on enhancing health outcomes for children with medical complexities, particularly in neonatal intensive care units (NICUs). Incorporated in 2016 and based in Yardley, Pennsylvania, the company develops software that delivers a comprehensive view of clinical data in real time, specifically aimed at assessing the gut health of preterm infants. This platform allows clinical care teams to standardize and optimize feeding practices and protocol-driven care, thereby facilitating informed decision-making. Astarte Medical's suite of digital tools and predictive analytics supports nutrition and feeding practices, enabling healthcare providers to monitor growth and track clinical outcomes effectively. By improving care practices in acute settings, the company strives to make a significant impact on the long-term health of vulnerable pediatric populations.

RecoveryLink provides a comprehensive Platform-as-a-Service (PaaS) digital platform for recovery support. It offers an electronic recovery record, asynchronous digital training, one-on-one telerecovery peer services, and live video group-based recovery supports.

iOrtho+ is a medical software company specializing in orthopedic care through its innovative product, the Mobil-Aider. This web-based application is designed to quantify joint mobility and allows clinicians to assess at least 14 motions across five different joints. The Mobil-Aider features a vast array of resources, offering 450 tests, 1,300 references, and 100 mobilization techniques. It serves as a comprehensive reference tool for orthopedic professionals, providing concise descriptions, images, videos, and statistical data, all of which enhance the clinician's ability to improve treatment outcomes and techniques.

Mediscore Health, founded in 2017, is based in Philadelphia, Pennsylvania with an additional location in Santa Monica, California. The company specializes in providing data-driven insights for healthcare solutions, focusing on chronic care management and risk adjustment for Medicare Advantage payers and Accountable Care Organizations (ACOs). Mediscore Health offers services such as physician-driven chart review and analytics, predictive diagnostics, and point-of-care disease management. Their technology-enabled approach is designed to help providers diagnose, document, and manage chronically ill patients effectively at the primary care level.

Cassian Solutions, Inc. is a company based in Phoenixville, Pennsylvania, that specializes in developing innovative medication management solutions. Founded in 2018, it designs and manufactures a unique phone case medication dispenser alongside a comprehensive application that enhances patient adherence to prescribed treatments. The app features tools for outcome collection, biometric verification, medication reminders, adherence verification, environmental sensing, treatment analysis, real-time communication, and medication distribution. Cassian Solutions serves a diverse clientele, including pharmacies, clinical trial companies, drug manufacturers, and insurers. By addressing critical gaps in patient monitoring and data reporting, the company aims to improve health outcomes and streamline the pharmaceutical value chain, ultimately enhancing the medication experience for patients and healthcare providers alike.

DRSLINQ is developing a mobile EKG device that is coupled to an interactive application powered by a natural language processing integrated with a machine learning platform to appropriately triage chest pain patients to the ER.

Astarte Medical Partners, Inc. is a clinical intelligence company focused on enhancing health outcomes for children with medical complexities, particularly in neonatal intensive care units (NICUs). Incorporated in 2016 and based in Yardley, Pennsylvania, the company develops software that delivers a comprehensive view of clinical data in real time, specifically aimed at assessing the gut health of preterm infants. This platform allows clinical care teams to standardize and optimize feeding practices and protocol-driven care, thereby facilitating informed decision-making. Astarte Medical's suite of digital tools and predictive analytics supports nutrition and feeding practices, enabling healthcare providers to monitor growth and track clinical outcomes effectively. By improving care practices in acute settings, the company strives to make a significant impact on the long-term health of vulnerable pediatric populations.

Tridiuum, Inc. is a digital health company that specializes in providing software solutions for behavioral health providers, patients, and health systems. Founded in 1997 and based in Philadelphia, the company operates a cloud-based platform known as Tridiuum1, which focuses on behavioral health outcomes management. This platform enables the monitoring of patients' symptoms and treatment progress, thereby enhancing patient experiences and outcomes in healthcare settings. Tridiuum's technology integrates digital health assessments with analytics to identify behavioral health issues, assign risk scores, and deliver real-time alerts at the point of care. Additionally, it supports features like video-based virtual visits, equipping clinicians to effectively evaluate, predict, and manage the care of patients facing various conditions. The company is driven by a team of experts in behavioral medicine and digital health technologies, with a strong clinical foundation rooted in research and evidence-based practices.

Keriton provides a digital platform for managing inpatient feeding, focusing on patient safety and improving nursing workflows. Its system tracks milk-bottle inventory, recipes, feeding orders, expiry dates, and more from mobile devices. It also offers a media-sharing platform for nurses to connect NICU babies with their mothers and delivers real-time insights into milk production patterns.

Shock Analytics LLC is an early-stage biomedical device company based in Philadelphia, Pennsylvania, established in 2016. The firm specializes in the design and manufacture of noninvasive diagnostic devices aimed at improving the management of acute and chronic illnesses. Its primary focus is on developing technology that estimates Systemic Vascular Resistance (SVR), a critical indicator for conditions such as congestive heart failure and sepsis. By utilizing hemodynamic information, Shock Analytics' devices enable healthcare professionals to effectively treat and monitor patients suffering from these serious medical conditions.

Instadiagnostics Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing a point-of-care (POC) diagnostic platform. Founded in 2015, the platform aims to bring centralized laboratory testing directly to patients at their bedside, facilitating early diagnosis and treatment monitoring. This innovative approach allows patients to receive timely medical care in various settings, including primary care centers, community clinics, and emergency departments, without the need for additional trips to have blood drawn or enduring long wait times for results. By streamlining the diagnostic process, Instadiagnostics seeks to enhance patient care and satisfaction, reduce the frequency of medical visits, and ultimately lower overall healthcare costs.

Instadiagnostics Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing a point-of-care (POC) diagnostic platform. Founded in 2015, the platform aims to bring centralized laboratory testing directly to patients at their bedside, facilitating early diagnosis and treatment monitoring. This innovative approach allows patients to receive timely medical care in various settings, including primary care centers, community clinics, and emergency departments, without the need for additional trips to have blood drawn or enduring long wait times for results. By streamlining the diagnostic process, Instadiagnostics seeks to enhance patient care and satisfaction, reduce the frequency of medical visits, and ultimately lower overall healthcare costs.

Grand Round Table Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing clinical decision support tools for healthcare providers. Its flagship product, Grand Round Table, is an integrated system designed to enhance the diagnostic capabilities of doctors by leveraging a vast database of deidentified health records, case reports, and evidence-based medical literature. This technology extracts pertinent information from patients' charts and matches it with similar cases, allowing physicians to reference previous treatments and outcomes in comparable scenarios. By facilitating faster and more accurate treatment plans, Grand Round Table aims to improve patient care, reduce unnecessary medical tests and consultations, and ultimately contribute to cost savings for hospitals and clinics. Established in 2011, the company focuses on translating available medical knowledge into actionable insights to support healthcare professionals in making informed decisions for diagnostically challenging cases.

Vy Corporation is a software development company based in Wayne, Pennsylvania, specializing in shape detection and object analysis for the medical imaging market. The company offers a cloud-based image analysis and data collection service known as CytoSavvy.com, which utilizes its patented CellQuant™ search technology to identify clusters of cells in various types of biopsies. This service aids pathologists and medical researchers by enhancing their ability to analyze complex cell structures efficiently and reliably. Additionally, Vy Corporation provides VectorSavvy.com, a platform that allows users to access image analysis technology, upload images, and view results. The company also engages in the development of custom projects tailored to specific client needs within the medical imaging sector.

Grand Round Table Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing clinical decision support tools for healthcare providers. Its flagship product, Grand Round Table, is an integrated system designed to enhance the diagnostic capabilities of doctors by leveraging a vast database of deidentified health records, case reports, and evidence-based medical literature. This technology extracts pertinent information from patients' charts and matches it with similar cases, allowing physicians to reference previous treatments and outcomes in comparable scenarios. By facilitating faster and more accurate treatment plans, Grand Round Table aims to improve patient care, reduce unnecessary medical tests and consultations, and ultimately contribute to cost savings for hospitals and clinics. Established in 2011, the company focuses on translating available medical knowledge into actionable insights to support healthcare professionals in making informed decisions for diagnostically challenging cases.

BioDetego is focused on advancing cancer diagnostics through its innovative platform, VASPfore, which develops a biomarker test aimed at optimizing cancer treatment protocols. This test assesses the metastatic risk in colorectal cancer patients, allowing for more informed decisions regarding chemotherapy. By accurately identifying high-risk patients who would benefit from treatment, BioDetego seeks to mitigate the unnecessary costs and adverse effects associated with treating low-risk patients. The company anticipates significant savings for payors, estimated at over $150 million annually, through reduced overall treatment expenses. BioDetego is led by David Zuzga, Ph.D., a research scientist with a background in cell and molecular biology, and Giovanni M. Pitari, M.D., Ph.D., a physician and research scientist specializing in Translational Oncology.

Fitly, Inc. specializes in developing innovative solutions that promote healthy eating among families and children. The company offers the SmartPlate App, which employs food recognition technology to assist users in planning, purchasing, and preparing nutritious meals. This app allows individuals to choose from various goal-specific programs or create custom plans, while pairing with a countertop device that accurately analyzes and tracks the nutritional content of meals. Fitly's SmartPlate TopView device provides personalized guidance on healthy eating habits by analyzing entire meals and offering insights into macro and micronutrient intake. The company's solutions focus on various aspects of wellness, including weight management, portion control, and dietary needs, aiming to enhance human health without the need for restrictive diets. Established in 2011, Fitly is headquartered in Philadelphia, Pennsylvania.

EyeIC, Inc. is a medical technology company based in Wayne, Pennsylvania, specializing in the development and commercialization of imaging technologies for healthcare applications. Founded in 2004, EyeIC focuses on providing innovative solutions for eye care professionals and clinics. One of its key products, MatchedFlicker, is designed to monitor the onset and progression of glaucoma by detecting changes in time series retinal photographs. The technology automates the alignment and registration of images taken at different times, generating a superimposed view that facilitates analysis. Additionally, EyeIC's platform includes built-in interpretation and reporting tools, streamlining documentation and claims submission while assisting clinicians in identifying various retinal conditions, including diabetic retinopathy and retinopathy of prematurity. Through its advancements, EyeIC aims to enhance clinical workflows and improve patient care in the field of ophthalmology.

CD Diagnostics is developing assays for orthopaedic surgeons and rheumatologists who would like greater diagnostic confidence in joint fluid analysis. Unlike current technologies, which often yield vague and ambiguous results, CygnaSure™, our lead product, offers orthopaedic surgeons and rheumatologists a rapid, accurate and reliable diagnostic answer.

Real Time Tomography, LLC is a company focused on developing innovative imaging software solutions for medical imaging systems, particularly in the field of breast cancer detection. Founded in 2006 and based in Villanova, Pennsylvania, the company offers products such as Adara, which enhances digital mammography images to improve tissue contrast and lesion visibility, and Briona, a 3D image reconstruction software that transforms 2D projection images into detailed 3D tomographic images. Real Time Tomography also provides technical support and consultation for optimizing detector and system design to enhance image quality and processing speed. Their solutions are primarily aimed at manufacturers of mammography systems and PACS workstations, contributing to advancements in diagnostic accuracy and clinical workflow efficiency in the healthcare sector.

Bionano Genomics, Inc. is a biotechnology company focused on genome mapping and analysis. It develops and markets the Saphyr system, an advanced platform designed for ultra-sensitive and specific detection of structural variations in DNA, such as insertions, deletions, and translocations, which are often linked to genetic disorders and diseases, including cancer. The Saphyr system employs optical genome mapping technology, allowing for direct visualization and analysis of long DNA molecules without relying on sequencing. This capability provides researchers and clinicians with critical insights into the structural variations within genomes, enhancing the understanding of disease mechanisms and supporting the development of personalized treatment strategies. Bionano Genomics also offers essential reagents and data solutions, including Bionano prep kits, labeling kits, and software tools for comprehensive experiment management. Its products are primarily sold to academic and governmental research laboratories, as well as pharmaceutical, biotechnology, and contract research organizations across multiple regions, including North America, Europe, and Asia. Founded in 2003 and headquartered in San Diego, California, the company was previously known as BioNano Genomics, Inc. until its name change in July 2018.